MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 179 filers reported holding MIRATI THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.52 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,592,000 | -34.3% | 9,000 | -40.0% | 0.01% | -33.3% |
| Q2 2021 | $2,422,000 | -46.0% | 15,000 | -42.7% | 0.01% | -47.1% |
| Q1 2021 | $4,488,000 | +84.1% | 26,200 | +136.0% | 0.02% | +88.9% |
| Q4 2020 | $2,438,000 | +133.1% | 11,100 | +76.2% | 0.01% | +125.0% |
| Q3 2020 | $1,046,000 | +66.8% | 6,300 | +14.5% | 0.00% | +33.3% |
| Q2 2020 | $627,000 | +202.9% | 5,500 | +103.7% | 0.00% | +200.0% |
| Q1 2020 | $207,000 | -33.0% | 2,700 | +12.5% | 0.00% | 0.0% |
| Q4 2019 | $309,000 | +33.2% | 2,400 | -20.0% | 0.00% | 0.0% |
| Q3 2019 | $232,000 | +50.6% | 3,000 | +100.0% | 0.00% | 0.0% |
| Q2 2019 | $154,000 | +83.3% | 1,500 | -68.8% | 0.00% | – |
| Q3 2014 | $84,000 | +75.0% | 4,800 | +100.0% | 0.00% | – |
| Q2 2014 | $48,000 | – | 2,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $688,784,000 | 67.42% |
| Avoro Capital Advisors LLC | 4,535,000 | $996,067,000 | 17.15% |
| Darwin Global Management, Ltd. | 260,876 | $57,299,000 | 15.99% |
| Boxer Capital, LLC | 1,765,560 | $387,788,000 | 12.46% |
| Perceptive Advisors | 3,693,516 | $811,244,000 | 8.71% |
| Consonance Capital Management LP | 330,000 | $72,481,000 | 6.77% |
| EcoR1 Capital, LLC | 464,298 | $101,978,000 | 5.48% |
| Fairmount Funds Management LLC | 60,500 | $13,288,000 | 4.75% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,400 | $14,804,000 | 4.04% |
| RTW INVESTMENTS, LP | 1,054,364 | $231,581,000 | 3.88% |